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CAM and a Challenging Pyramid
Pyramids touch us in many ways. According to a popular def-
inition which most of us will understand, a pyramid is a stone
structure with a flat (usually) square base and with sloping
sides that meet at the top, especially built by the ancient
Egyptians as a tomb or by the Aztecs and Mayas as a platform
for a temple, raised for edification. Then there are food pyra-
mids that propose to solve the obesity epidemic. How does
such a definition fit within the confines of complementary and
alternative medicine (CAM), eCAM and bioprospecting? What
is more, how do we move the ancient and familiar definition to
signify the 21st century pyramid and one that is relevant to
CAM? At the moment, I do not yet have data on the ancient
practices of the Egyptians nor the Aztecs and Mayas as their
approaches relate to CAM or to eCAM. We do know about his-
torical practices of similar ages in history from Japan and
Taiwan, just to cite two recent examples of rigorous presenta-
tions (1,2). The relevant CAM pyramid that I will detail could
continue to be a hard impenetrable structure unless we are
willing to in effect dismantle it, to deconstruct it from bottom
up from those points that gird it to unfavorable approaches that
are less acceptable in the evidence-based approach to CAM.
A pyramid has recently been published in Nature Immunology
entitled: ‘Complementary and alternative medicine: assessing
the evidence for immunological benefits’ (3). In this pyramid,
there is a hierarchy of evidence. Information regarding the
efficacy and safety of any clinical approach, including those
of CAM, spans a continuum that ranges at the base all the
way to the peak or the pyramid’s point, from anecdotes and
retrospective studies to small randomized, controlled trials
(phase II clinical trials) and large randomized, controlled trials
(phase III clinical trials). In my opinion, this paper and its
contents, and the pyramid represent a seminal tribute to the
role of the immune system in CAM.
NCCAM and CAM
At the national level CAM is becoming increasingly more
prominent in the scientific establishment especially in
immunology (3). There seems to be a focus on the innate
immune system especially the ubiquitous natural killer (NK)
cells (4,5). In terms of a comparative coverage of NK cells and
CAM, clearly that by Takeda and Okumura (4) is more recent,
thorough and extensive. Two of the tables, for example, cover
the known NK receptors and NK activation inducing CAM.
Some of the figures are equally informative and elegant.
Figure 1, for instance, treats NK cells in tumor surveillance,
relationships to cytokines and the critical role they play in the
inhibition of angiogensis by tumor development. In Figure 3,
there is an all-encompassing coverage of immune system con-
trol by the autonomic nervous system where there is depicted
the intimate cross-talk between NK cells and their control by
the autonomic nervous system.
In 1998, the National Center for Complementary and
Alternative Medicine (NCCAM) was established by the US
Congress at the National Institutes of Health (Bethesda, MD) to
investigate CAM modalities rigorously in order to determine
which are beneficial and worthy of further consideration for
mainstream practice. Among the many CAM approaches that
warrant careful investigation are those that claim to sustain,
restore or boost immunity. In this review, Goldrosen and Strauss
(3) covered the following topics: use of CAM, regulation of
CAM, risks of CAM use, clinical trials of CAM, CAM and
immunity, dietary supplements and mind–body approaches. In
Table 1, they cover some ongoing, large phase III trials of CAM
modalities; in Table 2 some CAM modalities that might mediate
their effects through the immune system; and in Table 3 some
herbal products that modulate immune responses. Their Box 1
warns of the challenges of conducting clinical trials of CAM.
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What about the aforementioned CAM pyramid? Depicted in
Figure 2 there is a hierarchy of evidence. This CAM pyramid
begins at the base with the least desirable of approaches such as
anecdotes and case studies which eCAM is being careful not to
publish unless backed by strong evidence and clear indications
of a scientific approach (6). The pinnacle or top of the pyramid
is represented by large randomized clinical trials. In ancient
mythical terms this height is a tribute to something higher!
Chemists, CAM and Kampo
This is more from the viewpoint of the biologist. Now it seems
that chemists are becoming involved in this international CAM
movement. Even popular coverage is an everyday occurrence
(7,8). Recently Professor Haruki Yamada, a member of the
Editorial Board of eCAM, informed me of his invitation to lec-
ture at a recent meeting of the American Chemical Society
held in San Diego, CA. Of enormous special interest for CAM
in general and of course eCAM was the American Chemical
Society’s Newsletter (9). In it there is substantial credit offered
to the entire sweep of CAM. Topics included: what is CAM,
the top 10 CAMs, how can chemists help? CAM chemical
prospecting and drawing a baseline. It is obvious why
Professor Yamada was appropriate as an invited participant at
this meeting because of his own work that promises an
approach to CAM using the evidence-based approach and
which has a distinct analytical chemical orientation.
According to Yamada (10) ‘the efficacy of Kampo medicines
cannot be explained by the pharmacological activity of just
one active ingredient, and several active ingredients may affect
the immune, endocrine, and neural systems of the whole body
by several combination effects such as synergistic and or
antagonistic effects’. Some of these active ingredients also
work through structural modifications to the actual active
compounds by endogenous factors such as intestinal bacteria
or gastric juice. Because standardization of natural medicine is
very important, indicator compounds, hopefully active ingre-
dients should control and fingerprint it using three-dimensional
HPLC. Analysis of pharmacological activity related to clinical
effects by in vitro and in vivo biological methods might also be
very important to obtain reproducible effects of herbs. In one
important figure, a three-dimensional HPLC pattern of one
Kampo formula, Juzen-taiho-to (SI-Quan-Da-Bu-Tang in
Chinese), is shown (11). Juzen-taiho-to has been used for the
treatment of patients recovering from surgery or suffering
from diseases by promoting the improvement of their debili-
tated general condition. Juzen-taiho-to also has been adminis-
tered to patients with anemia or anorexia. The clinical effects
observed suggest that the formula enhances immune responses
and improves the functioning of the hematopoietic systems.
Since it is possible to prepare HPLC fingerprinting patterns
based on the composition of the constituents in each formula,
this method is useful for the standardization of not only
Kampo medicines but also natural medicines.
Now let us put together the two approaches: biologists
(immunological focus of Goldrosen and Strauss) and those of
the chemists (Kampo of Yamada) and bioprospecting (Muller
and Cooper). As mentioned earlier and as the following reports
will confirm, there is a preponderance of focus and emphasis on
plants and little or no coverage of natural products from ani-
mals. Yet there is ample evidence as we have published recently
(5,13–15). Thus bioprospecting is a new frontier for CAM!
Bioprospecting: Invertebrates and
Natural Products
From Muller’s extensive work, we see a compendium of excel-
lent very supportive work for the real existence of useful prod-
ucts from animals. Examples of compounds that are already in
medical use [inhibition of tumor/virus growth (arabinofura-
nosyl cytosine and arabinofuranosyl adenine)], or are being
considered as lead structures [acting as cytostatic and anti-
inflammatory secondary metabolites (avarol/avarone), causing
induction of apoptosis (sorbicillactone)] or as prototypes for
the interference with metabolic pathways common in organisms
ranging from sponges to humans [modulation of pathways
activated by fungal components (aeroplysinin), inhibition of
angiogenesis (2-methylthio-1,4-napthoquinone), immune mod-
ulating activity (FK506)] are discussed in this study. In addi-
tion, bioactive proteins from sponges are listed [antibacterial
activity (pore-forming protein and tachylectin)]. Finally, it is
outlined that the skeletal elements—the spicules—serve as
blueprints for new biomaterials, especially those based on
biosilica, which might be applied in biomedicine. These
compounds and biomaterials have been isolated/studied by
members of the German Center of Excellence BIOTECmarin.
The citation of this prime example of what bioprospecting has
yielded has been derived from careful analyses of products
synthesized and secreted by sponges that are multicellular
members of the second animal phylum by classification, the
Porifera. 
CAM and Earthworm Natural Products
If we turn now to more complex multicellular species where
there is an enormous amount of information that is several cen-
turies old, witness the literature pertaining to the earthworm’s
healing properties (16). Earthworm lytic molecules are antimi-
crobial and may prove useful as antibacterial agents and pro-
phylatic molecules, an idea that is not far fetched since
the discovery of antibiotics was serendipitous. Two molecules,
lysenin and eiseniapore, depend to some extent on intracellular
lipid trafficking mechanisms. In fact, trafficking dysfunction
leads to disease development, such as Tangier disease and
Neumann–Pick disease type C, or contributes to the pathogen-
esis of diseases such as Alzheimer disease and atherosclerosis.
Lysenin reacts specifically with fibroblast membranes from
patients with Niemann–Pick disease, a rather curious finding,
but one that may have some clinical relevance (17). Thus
specific binding of lysenin to sphingomyelin on cellular
126 Editorialour study as if we are seeing them for the first time. By so
doing, we are able to re-think theories and hypotheses that
have been long accepted, and have the courage to embark on a
new search that will eventually lead to new and exciting heal-
ing modalities with a firm evidence base.
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membranes may prove to be a useful tool to probe the molec-
ular motion and function of sphingomyelin in biological mem-
branes, especially in an effort to explain the mechanism of
lysis in earthworms. These results stress the need for concerted
analyses of various lytic pathways that may be mediated by the
earthworm immunodefense system. Both the products of
sponges and those of other animals are of potential importance
as great as those being exploited from plants. The goal for the
future is successfully to introduce some of these compounds in
the treatment of human diseases in order to raise public aware-
ness on the richness and diversity of natural products that
could be carefully harvested for the benefit of mankind. This is
an example where the scientific approach presents solid evi-
dence that certain molecules are ready for testing.
CAM and an Informative Triangle:
A New Pyramid
Since for many scientists, entering the world of CAM has
challenged long-established ways of looking at the world, I
propose that for a moment we look at the pyramid in yet
another way and watch as it transforms itself into a triangle. In
its new form, the hierarchy disappears and we can see the bal-
ance of three separate elements and the relationships between
these parts. The triangle delineates the balance that is at the
core of many holistic medicines. One example of this is
Olalde’s triangle of health, introduced in our last issue of
eCAM. He describes the triangle as a ‘governing dynamic, that
survival potential of any living system depended on enhancing
the three constituents that structure its common denominator.
These essential factors are energy, intelligence and organiza-
tion—three sided but with no layering from bottom up. His
hypothesis under this scope proposes that the survival potential
(health) of every human being could be improved by a syner-
getic increase of any or all of these three factors because they
were interdependent (18). To paraphrase Olalde, the basis for
the hypothesis was the premise that the triangle’s integrity con-
stituted a reflection of the entropic status of the organism. This
could then be enhanced by providing survival energy and
information to the cells, furnishing negative entropy from
herbs, to create an endogenous healing tendency within the
body—called syntropy. This new view of an ancient structure
points to an essential quality of scientific research, especially
in the varied world of CAM: the ability to see the objects of